# Dutch Bros Inc.: financial statements, quarterly

BROS · NYSE · CIK 1866581 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bros.md) · [Financials](/companies/bros/financials.md) · [Filings](/companies/bros/filings.md) · [Insiders](/companies/bros/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bros/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [265](/filings/0001866581-24-000306.md) | [254 d](/filings/0001866581-26-000006.md) | [275](/filings/0001866581-25-000130.md) | [325](/filings/0001866581-25-000186.md) | [338](/filings/0001866581-25-000227.md) | [343 d](/filings/0001866581-26-000006.md) | [355](/filings/0001866581-26-000078.md) | [416](/filings/0001866581-26-000133.md) | [424](/filings/0001866581-25-000227.md) | [444 d](/filings/0001866581-26-000006.md) | [464](/filings/0001866581-26-000078.md) | [551](/filings/0001866581-26-000133.md) |
| Cost of revenue | $m | [189](/filings/0001866581-24-000306.md) | [195 d](/filings/0001866581-26-000006.md) | [203](/filings/0001866581-25-000130.md) | [235](/filings/0001866581-25-000186.md) | [248](/filings/0001866581-25-000227.md) | [255 d](/filings/0001866581-26-000006.md) | [265](/filings/0001866581-26-000078.md) | [296](/filings/0001866581-26-000133.md) | [317](/filings/0001866581-25-000227.md) | [336 d](/filings/0001866581-26-000006.md) | [357](/filings/0001866581-26-000078.md) | [400](/filings/0001866581-26-000133.md) |
| Selling, general and administrative | $m | [50.5](/filings/0001866581-24-000306.md) | [56.9 d](/filings/0001866581-26-000006.md) | [46.2](/filings/0001866581-25-000130.md) | [58.1](/filings/0001866581-25-000186.md) | [57.5](/filings/0001866581-25-000227.md) | [72.2 d](/filings/0001866581-26-000006.md) | [58.9](/filings/0001866581-26-000078.md) | [65.4](/filings/0001866581-26-000133.md) | [65.3](/filings/0001866581-25-000227.md) | [73.2 d](/filings/0001866581-26-000006.md) | [73.2](/filings/0001866581-26-000078.md) | [80.7](/filings/0001866581-26-000133.md) |
| Operating income | $m | [24.7](/filings/0001866581-24-000306.md) | [2.2 d](/filings/0001866581-26-000006.md) | [25.6](/filings/0001866581-25-000130.md) | [32.2](/filings/0001866581-25-000186.md) | [32.5](/filings/0001866581-25-000227.md) | [15.8 d](/filings/0001866581-26-000006.md) | [31.1](/filings/0001866581-26-000078.md) | [54.7](/filings/0001866581-26-000133.md) | [41.5](/filings/0001866581-25-000227.md) | [34.0 d](/filings/0001866581-26-000006.md) | [34.3](/filings/0001866581-26-000078.md) | [70.4](/filings/0001866581-26-000133.md) |
| Income tax | $m | [1.8](/filings/0001866581-24-000306.md) | [0.7 d](/filings/0001866581-26-000006.md) | [8.8](/filings/0001866581-25-000130.md) | [3.9](/filings/0001866581-25-000186.md) | [4.7](/filings/0001866581-25-000227.md) | [1.1 d](/filings/0001866581-26-000006.md) | [1.5](/filings/0001866581-26-000078.md) | [7.2](/filings/0001866581-26-000133.md) | [7.7](/filings/0001866581-25-000227.md) | [2.0 d](/filings/0001866581-26-000006.md) | [3.3](/filings/0001866581-26-000078.md) | [12.6](/filings/0001866581-26-000133.md) |
| Net income | $m | [4.2](/filings/0001866581-24-000306.md) | [(1.4) d](/filings/0001866581-26-000006.md) | [7.1](/filings/0001866581-25-000130.md) | [11.9](/filings/0001866581-25-000186.md) | [12.6](/filings/0001866581-25-000227.md) | [3.6 d](/filings/0001866581-26-000006.md) | [15.4](/filings/0001866581-26-000078.md) | [25.6](/filings/0001866581-26-000133.md) | [17.5](/filings/0001866581-25-000227.md) | [21.4 d](/filings/0001866581-26-000006.md) | [16.1](/filings/0001866581-26-000078.md) | [37.4](/filings/0001866581-26-000133.md) |
| Diluted EPS | $ per share | [0.07](/filings/0001866581-24-000306.md) | not reported | [0.08](/filings/0001866581-25-000130.md) | [0.12](/filings/0001866581-25-000186.md) | [0.11](/filings/0001866581-25-000227.md) | not reported | [0.13](/filings/0001866581-26-000078.md) | [0.20](/filings/0001866581-26-000133.md) | [0.14](/filings/0001866581-25-000227.md) | not reported | [0.13](/filings/0001866581-26-000078.md) | [0.28](/filings/0001866581-26-000133.md) |
| Basic EPS | $ per share | [0.07](/filings/0001866581-24-000306.md) | not reported | [0.08](/filings/0001866581-25-000130.md) | [0.12](/filings/0001866581-25-000186.md) | [0.11](/filings/0001866581-25-000227.md) | not reported | [0.13](/filings/0001866581-26-000078.md) | [0.20](/filings/0001866581-26-000133.md) | [0.14](/filings/0001866581-25-000227.md) | not reported | [0.13](/filings/0001866581-26-000078.md) | [0.28](/filings/0001866581-26-000133.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [150](/filings/0001866581-23-000131.md) | [134](/filings/0001866581-25-000048.md) | [263](/filings/0001866581-24-000134.md) | [261](/filings/0001866581-24-000217.md) | [281](/filings/0001866581-24-000306.md) | [293](/filings/0001866581-26-000006.md) | [316](/filings/0001866581-25-000130.md) | [254](/filings/0001866581-25-000186.md) | [267](/filings/0001866581-25-000227.md) | [269](/filings/0001866581-26-000133.md) | [264](/filings/0001866581-26-000078.md) | [269](/filings/0001866581-26-000133.md) |
| Current assets | $m | [221](/filings/0001866581-23-000131.md) | [205](/filings/0001866581-25-000048.md) | [335](/filings/0001866581-24-000134.md) | [335](/filings/0001866581-24-000217.md) | [342](/filings/0001866581-24-000306.md) | [358](/filings/0001866581-26-000006.md) | [383](/filings/0001866581-25-000130.md) | [326](/filings/0001866581-25-000186.md) | [341](/filings/0001866581-25-000227.md) | [357](/filings/0001866581-26-000133.md) | [340](/filings/0001866581-26-000078.md) | [352](/filings/0001866581-26-000133.md) |
| Total assets | $m | [1,639](/filings/0001866581-23-000131.md) | [1,764](/filings/0001866581-25-000048.md) | [2,073](/filings/0001866581-24-000134.md) | [2,377](/filings/0001866581-24-000217.md) | [2,432](/filings/0001866581-24-000306.md) | [2,501](/filings/0001866581-26-000006.md) | [2,765](/filings/0001866581-25-000130.md) | [2,812](/filings/0001866581-25-000186.md) | [2,922](/filings/0001866581-25-000227.md) | [3,009](/filings/0001866581-26-000133.md) | [3,105](/filings/0001866581-26-000078.md) | [3,377](/filings/0001866581-26-000133.md) |
| Current liabilities | $m | [121](/filings/0001866581-23-000131.md) | [138](/filings/0001866581-25-000048.md) | [147](/filings/0001866581-24-000134.md) | [153](/filings/0001866581-24-000217.md) | [180](/filings/0001866581-24-000306.md) | [203](/filings/0001866581-26-000006.md) | [197](/filings/0001866581-25-000130.md) | [199](/filings/0001866581-25-000186.md) | [224](/filings/0001866581-25-000227.md) | [240](/filings/0001866581-26-000133.md) | [255](/filings/0001866581-26-000078.md) | [261](/filings/0001866581-26-000133.md) |
| Total liabilities | $m | [968](/filings/0001866581-23-000131.md) | [1,088](/filings/0001866581-25-000048.md) | [1,377](/filings/0001866581-24-000134.md) | [1,647](/filings/0001866581-24-000217.md) | [1,679](/filings/0001866581-24-000306.md) | [1,737](/filings/0001866581-26-000006.md) | [1,969](/filings/0001866581-25-000130.md) | [1,978](/filings/0001866581-25-000186.md) | [2,057](/filings/0001866581-25-000227.md) | [2,111](/filings/0001866581-26-000133.md) | [2,185](/filings/0001866581-26-000078.md) | [2,402](/filings/0001866581-26-000133.md) |
| Long-term debt | $m | [92.7](/filings/0001866581-23-000131.md) | [93.2](/filings/0001866581-25-000048.md) | [234](/filings/0001866581-24-000134.md) | [229](/filings/0001866581-24-000217.md) | [224](/filings/0001866581-24-000306.md) | [220](/filings/0001866581-26-000006.md) | [261](/filings/0001866581-25-000130.md) | [197](/filings/0001866581-25-000186.md) | [196](/filings/0001866581-25-000227.md) | [196](/filings/0001866581-26-000133.md) | [195](/filings/0001866581-26-000078.md) | [195](/filings/0001866581-26-000133.md) |
| Current portion of debt | $m | [3.9](/filings/0001866581-23-000131.md) | [4.5](/filings/0001866581-25-000048.md) | [12.6](/filings/0001866581-24-000134.md) | [14.2](/filings/0001866581-24-000217.md) | [15.7](/filings/0001866581-24-000306.md) | [17.3](/filings/0001866581-26-000006.md) | [22.6](/filings/0001866581-25-000130.md) | [3.9](/filings/0001866581-25-000186.md) | [3.9](/filings/0001866581-25-000227.md) | [3.9](/filings/0001866581-26-000133.md) | [3.9](/filings/0001866581-26-000078.md) | [3.9](/filings/0001866581-26-000133.md) |
| Shareholders' equity | $m | [332](/filings/0001866581-23-000131.md) | [364](/filings/0001866581-25-000048.md) | [417](/filings/0001866581-24-000134.md) | [509](/filings/0001866581-24-000217.md) | [523](/filings/0001866581-24-000306.md) | [537](/filings/0001866581-26-000006.md) | [599](/filings/0001866581-25-000130.md) | [636](/filings/0001866581-25-000186.md) | [657](/filings/0001866581-25-000227.md) | [681](/filings/0001866581-26-000133.md) | [696](/filings/0001866581-26-000078.md) | [798](/filings/0001866581-26-000133.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [49.1 d](/filings/0001866581-24-000306.md) | [45.0 d](/filings/0001866581-26-000006.md) | [41.2](/filings/0001866581-25-000130.md) | [59.5 d](/filings/0001866581-25-000186.md) | [83.5 d](/filings/0001866581-25-000227.md) | [62.2 d](/filings/0001866581-26-000006.md) | [36.9](/filings/0001866581-26-000078.md) | [89.9 d](/filings/0001866581-26-000133.md) | [89.1 d](/filings/0001866581-25-000227.md) | [79.6 d](/filings/0001866581-26-000006.md) | [84.7](/filings/0001866581-26-000078.md) | [112 d](/filings/0001866581-26-000133.md) |
| Capital expenditure | $m | [65.4 d](/filings/0001866581-24-000306.md) | [60.7 d](/filings/0001866581-26-000006.md) | [57.5](/filings/0001866581-25-000130.md) | [64.4 d](/filings/0001866581-25-000186.md) | [57.1 d](/filings/0001866581-25-000227.md) | [42.8 d](/filings/0001866581-26-000006.md) | [45.6](/filings/0001866581-26-000078.md) | [54.2 d](/filings/0001866581-26-000133.md) | [70.2 d](/filings/0001866581-25-000227.md) | [71.2 d](/filings/0001866581-26-000006.md) | [57.0](/filings/0001866581-26-000078.md) | [72.3 d](/filings/0001866581-26-000133.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [54.4](/filings/0001866581-23-000131.md) | [56.7](/filings/0001866581-24-000134.md) | [57.4](/filings/0001866581-24-000217.md) | [60.2](/filings/0001866581-24-000306.md) | [83.4](/filings/0001866581-25-000130.md) | [102](/filings/0001866581-25-000186.md) | [114](/filings/0001866581-25-000227.md) | [122](/filings/0001866581-26-000078.md) | [127](/filings/0001866581-26-000133.md) | [127](/filings/0001866581-25-000227.md) | [127](/filings/0001866581-26-000078.md) | [135](/filings/0001866581-26-000133.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.